Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Adaptimmune Therapeutics PLC | 933,317 | reported | 03 Jul 2023 | tx 12+3,183,576 |
| Vir Biotechnology, Inc. | 16,000 | reported | 27 May 2026 | tx 18+215,589 |
| ALNYLAM PHARMACEUTICALS, INC. | 1,441 | reported | 20 May 2026 | tx 7+17,583 |
| Surface Oncology, Inc. | 0 | reported | 08 Sept 2023 | tx 11+139,403−259,089 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 27 May 2026 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 27 May 2026 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 671 | 0.00 USD | |
| 20 May 2026 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,441 | 0.00 USD | deriv |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 30 May 2025 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 775 | 0.00 USD | |
| 08 May 2025 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 1,558 | 0.00 USD | deriv |
| 30 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 8,000 | 0.00 USD | |
| 30 May 2024 | GRANT_AWARD | Vir Biotechnology, Inc. | 16,000 | 0.00 USD | deriv |
| 16 May 2024 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 5,228 | 0.00 USD | deriv |
| 08 Sept 2023 | OTHER | Surface Oncology, Inc. | 45,453 | — | |
| 08 Sept 2023 | OTHER | Surface Oncology, Inc. | 113,636 | 0.00 USD | deriv |
| 03 Jul 2023 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 933,317 | 0.00 USD | deriv |
| 22 May 2023 | GRANT_AWARD | Vir Biotechnology, Inc. | 6,027 | 0.00 USD | |
| 22 May 2023 | GRANT_AWARD | Vir Biotechnology, Inc. | 12,054 | 0.00 USD | deriv |
| 18 May 2023 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 3,454 | 0.00 USD | deriv |
| 01 Mar 2023 | PURCHASE | Vir Biotechnology, Inc. | 2,500 | 22.73 USD | |
| 05 Jan 2023 | PURCHASE | Vir Biotechnology, Inc. | 2,500 | 24.96 USD | |
| 03 Jan 2023 | PURCHASE | Vir Biotechnology, Inc. | 2,500 | 25.60 USD | first after silence |
| 04 Jan 2023 | PURCHASE | Vir Biotechnology, Inc. | 2,500 | 25.25 USD | |
| 22 Aug 2022 | GRANT_AWARD | ALNYLAM PHARMACEUTICALS, INC. | 4,456 | 0.00 USD | deriv |
| 01 Jul 2022 | GRANT_AWARD | Adaptimmune Therapeutics PLC | 737,050 | 0.00 USD | deriv |
| 08 Jun 2022 | GRANT_AWARD | Surface Oncology, Inc. | 24,000 | 0.00 USD | deriv |
| 23 May 2022 | GRANT_AWARD | Vir Biotechnology, Inc. | 6,405 | 0.00 USD |
1 purchase reported after at least 12 months of silence — most recent on 03 Jan 2023.